Enhancing Pediatric Bone Age Assessment Using Artificial Intelligence: Implications for Orthopedic Surgery

利用人工智能增强儿童骨龄评估:对骨科手术的启示

阅读:2

Abstract

Background Bone age assessment is a critical tool in pediatric orthopedic surgery, guiding treatment decisions for growth-related disorders and surgical interventions. Traditional methods, such as the Greulich-Pyle and Tanner-Whitehouse techniques, rely on manual interpretation of hand and wrist radiographs, making them time-intensive and susceptible to inter-operator variability. Artificial intelligence (AI) has emerged as a promising tool to enhance accuracy, efficiency, and standardization in skeletal maturity assessment. Methods This study evaluates the application of AI in pediatric bone age prediction using the Radiological Society of North America (RSNA) 2017 Pediatric Bone Age Challenge dataset. A deep learning model based on the ResNet-50 architecture (Microsoft Research, Redmond, Washington, USA) was developed and trained on 12,611 hand and wrist radiographs, validated on 1,425 images, and tested on 200 images. Model performance was assessed using root mean square error (RMSE), mean absolute error (MAE), and coefficient of determination (R²). Results The AI model achieved an RMSE of 11.07 months, an MAE of 8.54 months, and an R² of 0.929, indicating strong alignment with radiologist-determined bone ages. The Pearson correlation coefficient (0.963) and Spearman's rank correlation (0.955) confirmed the model's predictive robustness. Compared to traditional methods, which have reported variability with errors ranging from 6 to 18 months, the AI model demonstrated a reduction in inter-operator variability and improved reliability. Conclusion The implementation of AI in bone age assessment offers a more standardized, rapid, and precise alternative to conventional methods. By improving the accuracy and efficiency of skeletal maturity evaluations, AI has significant implications for pediatric orthopedic surgery, optimizing treatment timing and expanding access to high-quality bone age assessments. Further validation studies are needed to ensure clinical applicability across diverse patient populations.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。